News for Viatris Inc Registered Shs

TipRanks 4d

Viatris (VTRS) Receives a New Rating from Goldman Sachs

Seeking Alpha 4d

Teva, Amneal rated Buy, Viatris Neutral as Goldman Sachs reviews generics space

Seeking Alpha 5d

Theravance and Viatris settle patent dispute with Eugia Pharma

TipRanks 5d

Viatris initiated with a Neutral at Goldman Sachs

TipRanks 6d

Viatris management to meet with Piper Sandler

Seeking Alpha 8d

Viatris sees positive top-line phase 3 results for night driving impairment asset

TipRanks 9d

Viatris announces ‘positive’ results from Phase 3 trial evaluating MR-142

TipRanks 15d

Bronstein, Gewirtz & Grossman announces class action lawsuit against Viatris

TipRanks 20d

Viatris (VTRS) Gets a Hold from Piper Sandler

TipRanks 20d

FTC renews Orange Book listing disputes

TipRanks 26d

VTRS Lawsuit Alert! Class Action Lawsuit Against Viatris Inc.

Seeking Alpha 28d

S&P 500 turns positive for 2025; here are its best and worst YTD performers

Seeking Alpha 31d

Notable healthcare headlines for the week: Viatris, Novavax and UnitedHealth in focus

Seeking Alpha 32d

SA analyst downgrades: VTRS, MRVL, MAR, NTR, CRSP, DB, VRSK, OCSL

TipRanks 33d

Viatris files automatic mixed securities shelf

Seeking Alpha 34d

Biggest stock movers Thursday: Crypto stocks, BYND, CLF, VTRS, G, and more

TipRanks 34d

Early notable gainers among liquid option names on May 8th

Seeking Alpha 34d

Viatris rises as Q1 beat comes with late-stage trial wins

Seeking Alpha 34d

Viatris hits main goals in Phase 3 trial for birth control patch

Seeking Alpha 34d

Viatris in charts: Generic sales drop 16% in Q1; revenue from Developed Markets falls 13%

Seeking Alpha 34d

Viatris rises as late-stage trials for non-opioid pain therapy succeed

Seeking Alpha 34d

Viatris Non-GAAP EPS of $0.50 beats by $0.01, revenue of $3.25B beats by $10M

Seeking Alpha 34d

Viatris Q1 Earnings Preview: Analysts expect profit to decline by about 27%

Seeking Alpha 35d

Viatris declares $0.12 dividend

Seeking Alpha 36d

Heron settles patent dispute with Viatris over antiemetic agents

Seeking Alpha 36d

Viatris pulls generic for Teva’s Trisenox in EU

Seeking Alpha 38d

Earnings week ahead: AMD, PLTR, F, DIS, SHOP, DKNG, AMC, LCID, GOLD, RIVN, and more

Seeking Alpha 38d

About 78% of the names that reported earnings this week delivered EPS wins: Earnings Scorecard

Seeking Alpha 38d

Healthcare sector flexes earnings muscle, but top-line cracks show

TipRanks 43d

Piper Sandler Sticks to Its Hold Rating for Viatris (VTRS)

Seeking Alpha 43d

Viatris on track to close seventh straight session of gains

TipRanks 44d

Early notable gainers among liquid option names on April 28th

TipRanks 51d

Viatris price target lowered to $8 from $10 at BofA

TipRanks 51d

Analysts Offer Insights on Healthcare Companies: Viatris (VTRS), Xtant Medical Holdings (XTNT) and Medtronic (MDT)

TipRanks 51d

Bank of America Securities Keeps Their Sell Rating on Viatris (VTRS)

TipRanks 51d

Viatris files Effexor supplemental new drug applications to Japan MHLW

TipRanks 58d

Viatris appoints Hemanth Varghese as chief strategy officer

Seeking Alpha 62d

Pharma, MedTech stocks bounce back as Trump pauses most tariffs

Seeking Alpha 63d

Bristol-Myers gets Pomalyst antitrust case dismissed

Seeking Alpha 65d

Viatris to pay up to $335M to settle opioid-related claims

TipRanks 65d

Viatris reaches nationwide settlement to resolve opioid-related claims

Seeking Alpha 69d

Pharmaceuticals excluded from tariffs announced by Trump

Seeking Alpha 71d

CVS, COR, among top S&P 500 healthcare gainers in Q1; WST and MRNA among losers

TipRanks 71d

Viatris put volume heavy and directionally bearish

Seeking Alpha 78d

Trump reiterates plan to impose tariffs on pharmaceuticals

TipRanks 89d

Concerns increase around adverse effects of benzodiazepines, WSJ says

TipRanks 95d

Viatris price target lowered to $13 from $15 at Jefferies

TipRanks 98d

Viatris price target lowered to $10 from $14 at Piper Sandler

TipRanks 98d

Piper Sandler Sticks to Its Hold Rating for Viatris (VTRS)

Seeking Alpha 98d

Generic drugmakers could see negative impact from higher Chinese tariffs